오리엔트바이오

002630KOSPI의약품 제조업

62.3 / 100

Reference Date: 2026-07-24

Financial Score13.0 / 40

News Sentiment20.3 / 25

Momentum19.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is low with sound financial health but ROE is below the industry average. Rose 11.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Orient Bio operates in the biotechnology infrastructure sector, specializing in SPF egg production, CRO clinical trial services, and the development of bio-experimental equipment and biological materials, while adhering to international standards such as ICH, GLP, and GMP. The biotechnology industry, characterized by high added value and growth potential, is a key focus area for the company, contributing to healthcare, research, and pharmaceutical sectors.

Number of Employees

123people

Average Salary

32.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 11.234.0Point

PBR

0.81Industry Average 0.814.0Point

In line with industry avg

ROE

-16.82Industry Average 4.010.0Point

Well below industry avg

Debt Ratio

12.14Industry Average 12.434.0Point

In line with industry avg

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.1% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼260.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -0.2% (declining, 2yr)

Detailed News Sentiment

10 totalPositive 10Neutral 0Negative 0Average Sentiment Score 81

Positive
오리엔트바이오, 계열사 갤럭시 151만주 장내 매수
오리엔트바이오의 계열사 갤럭시가 주식을 매수하여 최대주주와 특수관계자의 지분이 확대되어 기업 가치 상승 기대감 증가.
Positive
오리엔트바이오, 영장류 비임상 데이터 'AI 자산화' 확대
오리엔트바이오의 AI 기반 비임상 데이터 축적 확대는 신약 개발 효율성 향상으로 긍정적 영향 기대.
Positive
오리엔트바이오 "연구용 영장류 공급 부족…CRO사업 수혜 기대"
오리엔트바이오는 연구용 영장류 공급 부족으로 CRO 사업 성장 기대.

Detailed Momentum

52-week position8.0Point

Near 52w high (86%, uptrend)

Current 980Won52-week high 1,06052-week low 467

1-month return5.0Point

1m +11.36% (rising)

Volume trend6.0Point

Volume surge

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-07-23
Neutral주주총회소집공고2026-07-16
Neutral주식등의대량보유상황보고서(일반)2026-07-08
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-06-29
Neutral정기주주총회결과2026-06-29